Expression of Concern: The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment

Addiction Biology - Tập 24 Số 4 - Trang 754-764 - 2019
Amir Ghaderi1, Hamid Reza Banafshe1,2, Naghmeh Mirhosseini3, Maryam Motmaen4, Fatemeh Mehrzad4, Fereshteh Bahmani5, Esmat Aghadavod5, Mohammad Alì Mansournia6, Rüssel J. Reiter7, Mohammad‐Amin Karimi8, Zatollah Asemi5
1Department of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
2Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
3Pure North S’Energy Foundation, Calgary, AB, Canada
4Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, Iran
5Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
6Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
7Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, TX USA
8Department of Educational Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

Tóm tắt

AbstractThis investigation was designed to determine the effect of melatonin supplementation on mental health parameters, metabolic and genetic profiles in patients under methadone maintenance treatment (MMT). This randomized, double‐blind, placebo‐controlled, clinical trial was conducted among 54 patients under MMT. Participants were randomly allocated to receive either 10 mg melatonin (2 melatonin capsules, 5 mg each) (n = 26) or placebo (n = 28) once a day, 1 hour before bedtime for 12 weeks. Melatonin supplementation significantly decreased Pittsburgh Sleep Quality Index (β −4.08; 95 percent CI, −5.51, −2.65; P < 0.001), Beck Depression Inventory index (β −5.46; 95% CI, −8.92, −2.00; P = 0.003) and Beck Anxiety Inventory index (β −3.87; 95% CI, −5.96, −1.77; P = 0.001) and significantly increased International Index of Erectile Functions (β 5.59; 95% CI, 1.76, 9.42; P = 0.005) compared with the placebo. Subjects who received melatonin supplements had significantly lower serum insulin levels (β −2.53; 95% CI, −4.48, −0.59; P = 0.01), homeostasis model of assessment‐insulin resistance (β −0.56; 95% CI, −1.03, −0.09; P = 0.01) and higher quantitative insulin sensitivity check index (β 0.01; 95% CI, 0.004, 0.02; P = 0.009) and HDL‐cholesterol levels (β 3.71; 95% CI, 1.77, 5.64; P = 0.002) compared to placebo. Additionally, melatonin intake resulted in a significant reduction in serum high sensitivity C‐reactive protein (β −0.15; 95% CI, −0.27, −0.02; P = 0.02), malondialdehyde (β −0.31; 95% CI, −0.57, −0.05; P = 0.02) and protein carbonyl (β −0.06; 95% CI, −0.09, −0.04; P < 0.001). This trial indicated that taking melatonin supplements for 12 weeks by patients under MMT had beneficial effects on their mental health metabolic profiles.

Từ khóa


Tài liệu tham khảo

10.1097/00005768-200009001-00009

10.1093/bja/aet153

10.1016/j.jcrc.2013.09.006

10.1097/j.pain.0000000000000284

10.1016/j.pbb.2014.06.021

10.1007/s00406-016-0711-8

10.1385/BTER:96:1-3:237

10.1037/0022-006X.56.6.893

10.1001/archpsyc.1961.01710120031004

10.1006/abio.1996.0292

10.1007/s00441-004-0976-5

Beutler E, 1985, Plasma glutathione in health and in patients with malignant disease, J Lab Clin Med, 105, 581

10.1016/j.pnpbp.2014.01.015

10.1016/0165-1781(89)90047-4

10.1016/j.psychres.2014.12.053

Chojnacki C, 2015, Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women, J Physiol Pharmacol, 66, 665

10.1038/oby.2010.24

10.1016/S0376-8716(03)00187-X

10.1038/nprot.2008.171

10.4239/wjd.v2.i6.82

10.1016/S0024-3205(97)00613-9

10.1080/10550880903436010

10.1203/00006450-200112000-00021

10.1111/j.1600-079X.2012.01023.x

10.1186/1758-5996-6-124

10.1007/s10654-015-9995-7

10.1007/s10549-014-2962-2

10.1016/j.euroneuro.2014.08.008

10.1007/s11655-014-1787-x

10.1016/0891-5849(90)90131-2

Khazaie H, 2016, Sleep Disorders in Methadone Maintenance Treatment Volunteers and Opium‐dependent Patients, Addict Health, 8, 84

10.1111/j.1600-079X.2010.00835.x

10.3390/ijms150915924

10.1016/S0924-977X(02)00175-X

10.1016/0076-6879(90)86141-H

10.1111/jpi.12308

10.7326/0003-4819-153-12-201012210-00004

10.1172/JCI57132

10.1002/hup.1068

10.1136/bjsports-2017-098245

10.1093/ije/dyt083

10.1097/EDE.0000000000000564

10.1111/j.1600-079X.2012.01014.x

Mesri Alamdari N, 2015, A double‐blind, placebo‐controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women, Horm Metab Res, 47, 504

10.1136/bjsports-2017-097759

10.4103/2277-9175.204593

10.1016/j.drugalcdep.2005.08.011

10.2337/dc12-0840

10.1159/000345122

10.1210/endo.140.2.6674

10.1016/j.clnu.2017.12.004

10.1111/jpi.12360

10.1007/s00018-017-2609-7

10.1046/j.1600-079X.2003.00092.x

10.1097/00001648-199001000-00010

10.1016/S0306-3623(96)00165-6

10.1034/j.1600-079X.2000.290207.x

10.1179/135100004225004814

10.1093/bja/aeq337

10.1177/1352458517738131

10.1080/15622970600571822

10.1111/j.1469-7610.1992.tb00951.x

10.1111/jpi.12257

10.1111/j.1600-079X.2008.00561.x

10.1016/j.clinbiochem.2010.12.011

10.1136/jmg.40.11.793

10.1111/j.1368-5031.2005.00571.x

10.1016/S0378-5122(00)00221-8

10.1111/jpi.12471